In this episode, we explore Psychodynamic Psychopharmacology, an innovative approach to treating medication-resistant patients. We discuss how psychological factors influence drug responses and learn techniques to enhance treatment outcomes. Could understanding the meaning patients attach to their medications be the key to unlocking treatment resistance?

Faculty: David Mintz, M.D. Host: Richard Seeber, M.D.

• Learn more about our memberships here
• Earn 1.75 CME: Psychodynamic Psychopharmacology: From Biomedical Approaches to Patient Relationships
• An Introduction to Psychodynamic Psychopharmacology

In this episode, we explore the complex relationship between benzodiazepine use and suicide risk, examining a groundbreaking French study that challenges our understanding of this connection. Is our go-to anxiety treatment potentially increasing suicide risk?

Faculty: Paul Zarkowski, M.D. Host: Richard Seeber, M.D.

• Learn more about our membership here
• Earn 0.5 CMEs: Quick Take Vol. 57
• Risk for Suicide Attempts and Suicide Associated With Benzodiazepines

In this episode, we explore how a psychodynamic approach can shed light on treatment-resistant cases. Can understanding a patient's psychological dynamics be the key to unlocking better outcomes?

Faculty: David Mintz, M.D. Host: Richard Seeber, M.D.

• Learn more about our memberships here
• Earn 1.75 CME: Psychodynamic Psychopharmacology: From Biomedical Approaches to Patient Relationships
• Understanding the Problem of Treatment Resistance

In this episode, we explore the fascinating connection between ADHD, pain sensitivity, and methylphenidate treatment in children. Could methylphenidate help reduce pain sensitivity in pediatric ADHD patients?

Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D.

• Learn more about our membership here
• Earn 0.5 CMEs: CAP Smart Takes Vol. 17
• Effect of Methylphenidate on Pain Perception Thresholds in Children With ADHD

In this episode, we dive into the complex world of treating insomnia in patients with major depressive disorder. What's the best approach to help these patients find restful sleep and improve their mood? Join us as we explore a range of strategies, from medication to behavioral interventions.

Faculty: Amit Chopra, M.D. Host: Richard Seeber, M.D.

• Learn more about our memberships here
• Earn 1.25 CME: Navigating Insomnia in Major Depressive Disorder: Advances in Management
• Treatment Strategies for Managing Insomnia in MDD

In this episode, we explore the latest pharmacologic interventions for managing insomnia in patients with major depressive disorder. Can dual orexin receptor antagonists, melatonin agonists, and low-dose doxepin provide relief for those struggling with sleep? Join us as we discuss the advances in treating insomnia and depression.

Faculty: Amit Chopra, M.D. Host: Richard Seeber, M.D.

• Learn more about our memberships here
• Earn 1.25 CMEs: Navigating Insomnia in Major Depressive Disorder: Advances in Management
• Other Pharmacologic Interventions for Insomnia

In this episode, we explore the potential of fish oil as an adjunct to cognitive–behavioral therapy for treating depression in youth. Can this combination enhance treatment outcomes, or is cognitive–behavioral therapy alone just as effective? Join us as we dive into this intriguing study.

Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D.

• Learn more about our membership here
• Earn 0.5 CMEs: CAP Smart Takes Vol. 16
• Is Fish Oil Effective in Youth Depression?

In this episode, we explore the use of benzodiazepines and nonbenzodiazepine hypnotics for managing insomnia in major depressive disorder. How do these medications work, and what are the key considerations when prescribing them? Join us as we navigate the complexities of pharmacologic interventions for insomnia.

Faculty: Amit Chopra, M.D. Host: Richard Seeber, M.D.

• Learn more about our memberships here
• Earn 1.25 CME: Navigating Insomnia in Major Depressive Disorder: Advances in Management
• Pharmacologic Interventions for Insomnia: Benzodiazepines and Non-Benzodiazepine Hypnotics

In this episode, we explore the safety of antipsychotics in patients with liver disease. How can psychiatrists navigate the risk–benefit balance when treating medically complex individuals? Dr. Sydney LeFay discusses key insights from a recent review article, guiding antipsychotic selection and monitoring.

Faculty: Sydney LeFay, D.O. Host: Richard Seeber, M.D.

• Learn more about our membership here
• Earn 0.75 CMEs: Quick Take Vol. 56
• Antipsychotic Safety in Liver Disease

In this episode, we explore the complex relationship between insomnia and major depressive disorder. How does insomnia impact the course and treatment of depression? Join us as we dive into the neurobiology and clinical implications of this fascinating topic with expert Dr. Amit Chopra.

Faculty: Amit Chopra, M.D. Host: Richard Seeber, M.D.

• Learn more about our memberships here
• Earn 1.25 CME: Navigating Insomnia in Major Depressive Disorder: Advances in Management
• Understanding the Relationship Between Insomnia Disorder and MDD